R Kilbourn. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Clinical Trials, Phase III as TopicDisease Models, AnimalDrug Evaluation, PreclinicalHumansNitric Oxide Synthase/antagonists & inhibitorsShock, Septic/drug therapyShock, Septic/mortalityShock, Septic/physiopathologySurvival AnalysisVascular Resistance/drug effects
Substances: See more » Nitric Oxide Synthase
Year: 1999 PMID: 10362395 DOI: 10.1097/00003246-199905000-00003
Source DB: PubMed Journal: Crit Care Med ISSN: 0090-3493 Impact factor: 7.598